Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabazitaxel for Cisplatin-resistant Germ Cell Tumors
NCT02478502Phase 2Terminated
- Start
- Jun 2015
- Primary completion
- Dec 2022
- Modality
- Allosteric Modulators
- Countries
- 4
01
Overview
A Phase 2 trial of cabazitaxel in Germ cell cancer (GCT). Started Jun 2015; status: terminated.
02
Drugs
cabazitaxel
03
Conditions
Germ cell cancer (GCT)
Beyond the preview
Go deeper on NCT02478502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02478502.